Shelton Capital Management Buys New Stake in Steris Plc (STE)

Shelton Capital Management bought a new position in shares of Steris Plc (NYSE:STE) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 5,692 shares of the medical equipment provider’s stock, valued at approximately $464,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Bragg Financial Advisors Inc acquired a new position in Steris Plc during the first quarter worth about $1,159,000. State of Wisconsin Investment Board acquired a new position in Steris Plc during the second quarter worth about $1,360,000. Morgan Stanley grew its position in Steris Plc by 28.3% during the first quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after buying an additional 58,776 shares during the period. Legal & General Group Plc grew its position in Steris Plc by 31.0% during the first quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after buying an additional 13,294 shares during the period. Finally, Schwab Charles Investment Management Inc. grew its position in Steris Plc by 31.2% during the second quarter. Schwab Charles Investment Management Inc. now owns 325,685 shares of the medical equipment provider’s stock worth $26,544,000 after buying an additional 77,516 shares during the period. Institutional investors own 93.33% of the company’s stock.

Steris Plc (STE) opened at 89.87 on Tuesday. The firm’s 50-day moving average is $87.21 and its 200 day moving average is $80.30. Steris Plc has a 12 month low of $63.80 and a 12 month high of $91.18. The firm has a market capitalization of $7.66 billion, a price-to-earnings ratio of 64.28 and a beta of 1.29.

Steris Plc (NYSE:STE) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The company had revenue of $608.00 million for the quarter, compared to the consensus estimate of $597.66 million. During the same period in the previous year, the firm earned $0.79 EPS. Steris Plc’s revenue was down 4.8% on a year-over-year basis. Equities analysts predict that Steris Plc will post $4.06 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.38%. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, August 25th. Steris Plc’s payout ratio is 88.57%.

ILLEGAL ACTIVITY WARNING: “Shelton Capital Management Buys New Stake in Steris Plc (STE)” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://ledgergazette.com/2017/10/10/shelton-capital-management-buys-new-stake-in-steris-plc-ste.html.

In other news, insider Michael J. Tokich sold 12,000 shares of Steris Plc stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $89.75, for a total value of $1,077,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris Plc stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total transaction of $856,900.00. Following the completion of the transaction, the chief executive officer now directly owns 83,270 shares in the company, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Insiders have sold a total of 194,086 shares of company stock worth $16,953,621 over the last 90 days. 2.55% of the stock is owned by insiders.

Several research analysts have weighed in on STE shares. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research upgraded shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price on the stock in a research report on Tuesday, July 11th. Finally, Raymond James Financial, Inc. upped their target price on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 9th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $89.00.

Steris Plc Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which

Other institutional investors and hedge funds also recently modified their holdings of the company. Bragg Financial Advisors Inc acquired a new position in Steris Plc during the first quarter worth about $1,159,000. State of Wisconsin Investment Board acquired a new position in Steris Plc during the second quarter worth about $1,360,000. Morgan Stanley grew its position in Steris Plc by 28.3% during the first quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock worth $18,514,000 after buying an additional 58,776 shares during the period. Legal & General Group Plc grew its position in Steris Plc by 31.0% during the first quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock worth $3,902,000 after buying an additional 13,294 shares during the period. Finally, Schwab Charles Investment Management Inc. grew its position in Steris Plc by 31.2% during the second quarter. Schwab Charles Investment Management Inc. now owns 325,685 shares of the medical equipment provider’s stock worth $26,544,000 after buying an additional 77,516 shares during the period. Institutional investors own 93.33% of the company’s stock.

Steris Plc (STE) opened at 89.87 on Tuesday. The firm’s 50-day moving average is $87.21 and its 200 day moving average is $80.30. Steris Plc has a 12 month low of $63.80 and a 12 month high of $91.18. The firm has a market capitalization of $7.66 billion, a price-to-earnings ratio of 64.28 and a beta of 1.29.

Steris Plc (NYSE:STE) last released its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. The company had revenue of $608.00 million for the quarter, compared to the consensus estimate of $597.66 million. During the same period in the previous year, the firm earned $0.79 EPS. Steris Plc’s revenue was down 4.8% on a year-over-year basis. Equities analysts predict that Steris Plc will post $4.06 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th were given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.38%. This is an increase from Steris Plc’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, August 25th. Steris Plc’s payout ratio is 88.57%.

ILLEGAL ACTIVITY WARNING: “Shelton Capital Management Buys New Stake in Steris Plc (STE)” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this article on another site, it was illegally stolen and republished in violation of United States and international copyright & trademark law. The legal version of this article can be read at https://ledgergazette.com/2017/10/10/shelton-capital-management-buys-new-stake-in-steris-plc-ste.html.

In other news, insider Michael J. Tokich sold 12,000 shares of Steris Plc stock in a transaction that occurred on Wednesday, October 4th. The shares were sold at an average price of $89.75, for a total value of $1,077,000.00. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of Steris Plc stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total transaction of $856,900.00. Following the completion of the transaction, the chief executive officer now directly owns 83,270 shares in the company, valued at approximately $7,135,406.30. The disclosure for this sale can be found here. Insiders have sold a total of 194,086 shares of company stock worth $16,953,621 over the last 90 days. 2.55% of the stock is owned by insiders.

Several research analysts have weighed in on STE shares. BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research upgraded shares of Steris Plc from a “hold” rating to a “buy” rating and set a $92.00 target price on the stock in a research report on Tuesday, July 11th. Finally, Raymond James Financial, Inc. upped their target price on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 9th. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $89.00.

Steris Plc Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Plc (NYSE:STE).

Institutional Ownership by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply